Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct-Dec;10(4):437-441.
doi: 10.4103/ijmy.ijmy_181_21.

Five-year trend analysis of tuberculosis in Bahir Dar, Northwest Ethiopia, 2015-2019

Affiliations

Five-year trend analysis of tuberculosis in Bahir Dar, Northwest Ethiopia, 2015-2019

Dagmawi Mengesha et al. Int J Mycobacteriol. 2021 Oct-Dec.

Abstract

Background: Tuberculosis (TB) remains a major cause of morbidity and mortality in Ethiopia despite the increased availability of effective treatments. Trend analysis of issues and priorities affecting TB programs across different regions of the country is critical to ensure equitable and sustainable TB outcomes. We aimed to analyze the trends of TB in Bahir Dar, Northwest Ethiopia, over 5 years from 2015 to 2019.

Methods: An institution-based, retrospective cross-sectional study was conducted in Bahir Dar, the capital city of the Amhara Region in Ethiopia. Five-year data and records of individual TB cases were reviewed from all public and private health-care facilities and health bureaus in Bahir Dar. Using a standard checklist adapted from the World Health Organization, data were abstracted relevant to sociodemographic characteristics of the patients, year and type of TB infection, and HIV status. SPSS version 20 software was used for data analysis.

Results: Data of 4275 patients with TB were identified, of which 929 (21.7%) were smear-positive pulmonary TB, 1195 (28%) were smear-negative pulmonary TB, and 2151 (50.3%) were extrapulmonary TB patients. TB was more prevalent in the age group 15-34 years (51.2%), and females (55.5%). In the years from 2015 to 2019, the prevalence of all forms of TB was 922 (21.6%), 812 (19.0%), 843 (19.7%), 876 (20.5%), and 822 (19.2%), respectively, demonstrating a decreasing trend though inconsistent. The variables sex (adjusted odds ratio [AOR]: 1.734, 95% confidence interval [CI] [1.390-2.187]), HIV co-infection (AOR: 1.875, 95% CI [1.553-2.265]), and age <15 years (AOR: 1.372, 95% CI [1.121-1.680]) showed a significant association with TB infection.

Conclusions: The prevalence of TB in Bahir Dar, Northwest Ethiopia, demonstrated a decreasing trend over the years from 2015 to 2019 but with inconsistencies. HIV co-infection significantly increased the risk of developing TB, and productive age groups and females were at the greater prevalence of TB, highlighting the importance of strengthening sustainable TB care and prevention interventions toward these groups of people.

Keywords: Ethiopia; TB-HIV co-infection; trend analysis; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1:
Figure 1:
Graph showing the prevalence of tuberculosis in Bahir Dar, Northwest Ethiopia, from January 1, 2015, to December 30, 2019

References

    1. World Health Organization (WHO). Global Tuberculosis Report 2020. Geneva, Switzerland; WHO; 2021. Available from: https://www.who.int/publications/i/item/9789240037021. [Last accessed on 2021 Oct 18]
    1. Said B, Charlie L, Getachew E, Wanjiru CL, Abebe M, Manyazewal T. Molecular bacterial load assay versus culture for monitoring treatment response in adults with tuberculosis. SAGE Open Med 2021;9:20503121211033470. - PMC - PubMed
    1. Acharya B, Acharya A, Gautam S, Ghimire SP, Mishra G, Parajuli N, et al. Advances in diagnosis of tuberculosis: An update into molecular diagnosis of Mycobacterium tuberculosis. Mol Biol Rep 2020;47:4065–75. - PubMed
    1. Getachew E, Adebeta T, Gebrie D, Charlie L, Said B, Assefa DG, et al. Pyrosequencing for diagnosis of multidrug and extensively drug-resistant tuberculosis: A systemic review and meta-analysis. J Clin Tuberc Other Mycobact Dis 2021;24:100254. - PMC - PubMed
    1. Borah P, Deb PK, Venugopala KN, Al-Shar’i NA, Singh V, Deka S, et al. Tuberculosis: An update on pathophysiology, molecular mechanisms of drug resistance, Newer Anti-TB Drugs, Treatment Regimens and Host- Directed Therapies. Curr Top Med Chem 2021;21:547–70. - PubMed